肠上皮质血清素作为治疗肠-大脑相互作用和情绪障碍的新目标
Lin Y Hung1, Nuno D Alves2, Andrew Del Colle1
1NYU Pain Research Center, Department of Molecular Pathobiology, College of Dentistry, New York University, New York, New York.
Gastroenterology
|December 13, 2024
概括
准肠道中的血清素再吸收载体,为治疗情绪障碍提供了一种没有副作用的新方法. 孕期SSRI暴露与婴儿肠-大脑相互作用障碍有关.
科学领域:
- 神经胃肠病学 神经胃肠病学
- 精神病学是一个精神病学.
- 发育儿科 发育儿科
背景情况:
- 情绪障碍和肠-大脑相互作用障碍 (DGBI) 是常见的,并发症的,治疗不良.
- 选择性血清素再吸收抑制剂 (SSRI) 是一线治疗方法,但会引起不良反应.
- 介导SSRI效应的特定部位以及妊娠期SSRI暴露对DGBI的影响尚不清楚.
研究的目的:
- 研究肠上皮质血清素再吸收载体 (SERT) 和血清素在情绪和肠道功能中的作用.
- 确定妊娠期SSRI暴露是否会增加DGBI风险.
- 确定参与情绪调节的肠-大脑通信通路.
主要方法:
- 利用转基因,手术和药理学模型研究肠道SERT和血清素.
- 研究了对情绪和胃肠功能的影响.
- 进行了关于妊娠期SSRI暴露和DGBI发展的前性出生队列研究.
主要成果:
- 向肠上皮层SERT切除改善了情绪,没有不良影响.
- 抑制上皮质血清合成恶化了类似情绪的行为.
- 不同的阴道通路调解肠道 - 血清激素对行为的影响.
- 在子宫内接触SSRI是DGBI的危险因素,特别是功能性便秘,在婴儿中.
结论:
- 肠道在情绪调节中发挥着关键作用.
- 肠道向疗法为情绪调节提供了一种新的方法.
- 孕期的SSRI暴露与婴儿DGBI发育有关.
相关概念视频
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
209
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
209
Irritable Bowel Syndrome I: Introduction
246
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
246
Drugs for Treatment of Diarrhea-Predominant IBS
147
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
147
Physiology of Enteric Nervous System and Gut Health
224
The gastrointestinal tract, responsible for the digestion and absorption of nutrients, is safeguarded by the intestinal barrier, which consists of secretory, physical, and immune components. At the forefront is the secretory barrier, composed of essential elements such as mucus, gut microbiota, and defense proteins. They collaborate to break down food particles, facilitate nutrient absorption, and maintain optimal gut health. These secretory components ensure the smooth functioning of the...
224
Enteric Nervous System: Regulation of GI Motor Activity
299
The Enteric Nervous System (ENS) plays a pivotal role in regulating gastrointestinal or GI motor activity. This complex network of nerves, deeply embedded within the gut wall, responds to changes in the gut environment and receives input from both the autonomic nervous system and the central nervous system. By doing so, the ENS operates various programs tailored to the body's nutritional status and needs.
During periods of fasting, the ENS initiates the migrating myoelectric complex, a...
During periods of fasting, the ENS initiates the migrating myoelectric complex, a...
299
Antidepressant Drugs: MAOIs and Other Agents
194
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
194


